[(3S)-3-[6-(3-fluorophenoxy)-2-pyridinyl]piperidin-1-yl]-[3-(imidazol-1-ylmethyl)phenyl]methanone
C27H25FN4O2 — CID 125010514
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(3S)-3-[6-(3-fluorophenoxy)-2-pyridinyl]piperidin-1-yl]-[3-(imidazol-1-ylmethyl)phenyl]methanone
[(3S)-3-[6-(3-fluorophenoxy)-2-pyridinyl]piperidin-1-yl]-[3-(imidazol-1-ylmethyl)phenyl]methanone (PubChem CID 125010514) has the molecular formula C27H25FN4O2 and a molecular weight of 456.52 g/mol. Its IUPAC name is [(3S)-3-[6-(3-fluorophenoxy)-2-pyridinyl]piperidin-1-yl]-[3-(imidazol-1-ylmethyl)phenyl]methanone.
Molecular Properties
| Compound Name | [(3S)-3-[6-(3-fluorophenoxy)-2-pyridinyl]piperidin-1-yl]-[3-(imidazol-1-ylmethyl)phenyl]methanone |
|---|---|
| PubChem CID | 125010514 |
| Molecular Formula | C27H25FN4O2 |
| Molecular Weight | 456.52 g/mol |
| Exact Mass | 456.20 |
| IUPAC Name | [(3S)-3-[6-(3-fluorophenoxy)-2-pyridinyl]piperidin-1-yl]-[3-(imidazol-1-ylmethyl)phenyl]methanone |
| SMILES | O=C(c1cccc(Cn2ccnc2)c1)N1CCC[C@H](c2cccc(Oc3cccc(F)c3)n2)C1 |
| InChI | InChI=1S/C27H25FN4O2/c28-23-8-2-9-24(16-23)34-26-11-3-10-25(30-26)22-7-4-13-32(18-22)27(33)21-6-1-5-20(15-21)17-31-14-12-29-19-31/h1-3,5-6,8-12,14-16,19,22H,4,7,13,17-18H2/t22-/m0/s1 |
| InChIKey | VJWNGAYNORILGF-QFIPXVFZSA-N |
| XLogP | 5.28 |
| TPSA | 60.25 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 456.52 |
| LogP ≤ 5 | 5.28 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 125010514 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.